Cent Eur J Public Health 2017, 25(1):46-54
Estimation of the Population Susceptibility Against Measles in Slovakia
- 1 Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
- 2 Department of Applied Mathematics and Statistics, Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
- 3 Division of Biomedical Physics, Department of Nuclear Physics and Biophysics, Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
Objective: In Slovakia, thanks to a highly effective vaccination programme, no domestic cases of measles have been reported since 1999. However, there are several outbreaks of measles currently hitting some countries in Europe. Difficulties in reaching the goal of measles elimination make it necessary to monitor the status of the population susceptibility to prevent similar outbreaks in the future. We hypothesize that immunity wanes overtime, which can substantially impact the population susceptibility. This work introduces a model that estimates a proportion of individuals susceptible to measles in the Slovak population in 2015.
Methods: Our analysis is based on an age-cohort model that incorporates waning immunity, vaccination schedule and changes in demographic structure. The inputs of the model are data on the vaccination coverage, last seroprevalence survey in 2002 and age structure of the population.
Results: In a short-term horizon, waning immunity does not affect the estimated proportion of the susceptible population. However, in a long-term horizon, the antibody titers can fall below the level of protection, which would result in a substantial transfer of initially immune individuals to the compartment of the susceptible ones. Incorporating of waning immunity in the cohort model has indicated that the most susceptible cohorts are not-vaccinated youngest children and cohorts born between 1969 and 1986.
Conclusions: Applying the model to the current situation shows that people aged 30-45 years and unvaccinated infants represent the most susceptible groups. Model partially replaces missing seroprevalence survey, but, because the parameters of model and phenomenon of waning immunity are not exactly known, we suggest reintroducing the regular national serosurveys in order to empirically determine the level of susceptibility for measles in Slovakia.
Keywords: measles, waning immunity, cohort model, vaccination, susceptibility
Received: August 30, 2016; Revised: February 6, 2017; Accepted: February 6, 2017; Published: March 1, 2017 Show citation
References
- Strebel PM, Papania MJ, Fiebelkorn AP, Halsey Na. Measles vaccine. In: Plotkin SA, Orenstein W, Offit PA. Vaccines. 6th ed. Philadelphia, PA: Elsevier; 2013. p. 352-87.
Go to original source...
- Lee MS, Nokes DJ. Predicting and comparing long-term measles antibody profiles of different immunization policies. Bull World Health Organ. 2001;79(7):615-24.
Go to PubMed...
- Glass K, Grenfell BT.Antibody dynamics in childhood diseases: waning and boosting of immunity and the impact of vaccination. J Theor Biol. 2003 Mar 7;221(1):121-31.
Go to original source...
Go to PubMed...
- Mossong J, O'Callaghan CJ, Ratnam S. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. Vaccine. 2000 Oct 15;19(4-5):523-9.
Go to original source...
Go to PubMed...
- Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008 Apr 1;197(7):950-6.
Go to original source...
Go to PubMed...
- LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007 Mar;161(3):294-301.
Go to original source...
Go to PubMed...
- Kremer JR, Schneider F, Muller CP. Waning antibodies in measles and rubella vaccinees - a longitudinal study. Vaccine. 2006 Mar 24;24(14):2594601.
Go to original source...
Go to PubMed...
- Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis. 2012 Nov 15;206(10):1542-8.
Go to original source...
Go to PubMed...
- Dine MS, Hutchins SS, Thomas A, Williams I, Bellini WJ, Redd SC. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination. J Infect Dis. 2004 May 1;189 Suppl 1:S123-30.
Go to original source...
Go to PubMed...
- Public Health Authority of the Slovak Republic. Annual reports of the Regional Public Health Authorities in the Slovak Republic [Internet]. Bratislava: Public Health Authority of the Slovak Republic [cited 2016 Feb14].Available from: http://www.uvzsr.sk/index.php?option=com_content&view=category&layout=blog&id=25&Itemid=34. (In Slovak.)
- Public HealthAuthority of the Slovak Republic. The annual report of the Public Health Authority of the Slovak Republic for 2005 year [Internet]. Bratislava: Public Health Authority of the Slovak Republic; 2006. [cited 2016 Feb 14].Available from: http://www.uvzsr.sk/docs/vs/vyrocna_sprava_uvz_sr_2005.pdf. (In Slovak.)
- DATAcube [Internet]. Bratislava: Statistical Office of the Slovak Republic [cited 2016 Feb 14]. Available from: http://datacube.statistics.sk/ TM1WebSK/.
- UzicaninA, Zimmerman L. Field effectiveness of live attenuated measlescontaining vaccines: a review of published literature. J Infect Dis. 2011 Jul;204 Suppl 1:S133-48.
Go to original source...
Go to PubMed...
- García-Comas L, Sanz Moreno JC, Ordobás Gavín M, Barranco Ordóñez D, García Gutiérrez J, Ramos Blázquez B, et al. Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008-2009. J Infect Public Health. 2015 Sep-Oct;8(5):432-40.
Go to original source...
Go to PubMed...
- Bílková-Fránková H, KloudováA, Zelená H, Tomášková H, Šebáková H, Martinková I, et al. Multipurpose serological survey (measles, mumps, pertussis, viral hepatitis B): SS 2013, Czech Republic: final report. Zpr Cent Epidemiol Mikrobiol. 2014;23 Suppl 1:1-152. (In Czech.)
- Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010 May 18;340:c1626. doi: 10.1136/bmj. c1626.
Go to original source...
Go to PubMed...
- Plans P, de Ory F, Campins M, Álvarez E, Payà T, Guisasola E, et al. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013. Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1161-71.
Go to original source...
Go to PubMed...
- Hens N, Abrams S, Santermans E, Theeten H, Goeyvaerts N, Lernout T, et al. Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. Euro Surveill. 2015 Jan 8;20(1). pii: 20998.
Go to original source...
Go to PubMed...
- Trmal J, Kupcová J, Dvořáková L, Vaculíkova D, Limberková R, Šlajová I, et al. Return of measles in Ústí Region. Epidemiol Mikrobiol Imunol. 2014;63(2):154-9. (In Czech.)
- Mossong J, Nokes DJ, Edmunds WJ, Cox MJ, Ratnam S, Muller CP. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol. 1999 Dec 1;150(11):1238-49. Accepted in revised formFebruary 6, 2017
Go to original source...
Go to PubMed...